Authors:
Griffith, TS
Kawakita, M
Tian, J
Ritchey, J
Tartaglia, J
Sehgal, I
Thompson, TC
Zhao, WC
Ratliff, TL
Citation: Ts. Griffith et al., Inhibition of murine prostate tumor growth and activation of immunoregulatory cells with recombinant canarypox viruses, J NAT CANC, 93(13), 2001, pp. 998-1007
Citation: Ts. Griffith et El. Broghammer, Suppression of tumor growth following intralesional therapy with TRAIL recombinant adenovirus, MOL THER, 4(3), 2001, pp. 257-266
Citation: Ts. Griffith et al., Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/apo-2 ligand gene induces tumor cell apoptosis, J IMMUNOL, 165(5), 2000, pp. 2886-2894
Authors:
Walczak, H
Miller, RE
Ariail, K
Gliniak, B
Griffith, TS
Kubin, M
Chin, W
Jones, J
Woodward, A
Le, T
Smith, C
Smolak, P
Goodwin, RG
Rauch, CT
Schuh, JCL
Lynch, DH
Citation: H. Walczak et al., Tumoricidal activity of tumor necrosis factor related apoptosis-inducing ligand in vivo, NAT MED, 5(2), 1999, pp. 157-163
Authors:
Algeciras-Schimnich, A
Griffith, TS
Lynch, DH
Paya, CV
Citation: A. Algeciras-schimnich et al., Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis, J IMMUNOL, 162(9), 1999, pp. 5205-5211
Authors:
Bonfoco, E
Stuart, PM
Brunner, T
Lin, T
Griffith, TS
Gao, Y
Nakajima, H
Henkart, PA
Ferguson, TA
Green, DR
Citation: E. Bonfoco et al., Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells, IMMUNITY, 9(5), 1998, pp. 711-720